Synovis Micro Purchases Rights to Neurotube

Paul, MN, USA), a wholly owned subsidiary of Synovis Life Technologies, Inc. (also in St. Paul), has purchased the rights to the Neurotube from Neuroregen, LLC (Bel Air, MD) for U.S.$1million in cash, plus earn-out and royalties over a five-year period.

The Neurotube is designed to help reconstruct nerves severed as a result of injury or disease. Using the Neurotube to repair nerve gaps eliminates the need for a second operation to harvest nerve tissue from another site on the patient. The second surgery often results in loss of sensation, external scarring, and pain. The use of nerve conduits has been proven to have greater success than nerve grafting. The Neurotube was cleared by the U.S. Food and Drug Administration (FDA) in 1999.

The Neurotube is a woven, corrugated tube made of polyglycolic acid (PGA), a material widely used for surgical repair. The tube is used in both primary and secondary nerve reconstruction surgeries. The tube remains intact during critical nerve gap regrowth and is subsequently absorbed by the body over a period of several months.

"Finding and acquiring niche market products has long been part of our diversification strategy, and the Neurotube fits that vision exactly,” remarked Karen Gilles Larson, president and CEO of Synovis Life Technologies.




Related Links:
Synovis Life Technologies